Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial

by José Luis Hernández, Francisco S Lozano, Vincent Riambau, Manuel Almendro-Delia, Juan Cosín-Sales, Sergi Bellmunt-Montoya, Javier Garcia-Alegria, Xavier Garcia-Moll, Juan José Gomez-Doblas, José R Gonzalez-Juanatey, Carmen Suarez Fernández
Published 2020-07-01